InvestorsHub Logo
Followers 11
Posts 546
Boards Moderated 0
Alias Born 08/18/2017

Re: Survivor2012 post# 440513

Tuesday, 02/01/2022 10:00:16 PM

Tuesday, February 01, 2022 10:00:16 PM

Post# of 704607
Not sure why he *would.

Why would he take the risk of associating himself with a clinical-stage platform for which efficacy has not been shown? It’s not even a success story yet.

He can’t even cite it as a promising new therapy. Overdone quiet period or not.

Maybe someday he can “for example” us. Not tomorrow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News